Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Current Deferred Revenue (2020 - 2025)

Metlife (MET) has 5 years of Current Deferred Revenue data on record, last reported at $5.1 billion in Q3 2025.

  • For Q3 2025, Current Deferred Revenue rose 7.68% year-over-year to $5.1 billion; the TTM value through Sep 2025 reached $5.1 billion, up 7.68%, while the annual FY2024 figure was $4.6 billion, 2.16% up from the prior year.
  • Current Deferred Revenue reached $5.1 billion in Q3 2025 per MET's latest filing, up from $4.9 billion in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $5.1 billion in Q3 2025 and bottomed at $3.6 billion in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $4.4 billion, with a median of $4.5 billion recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: increased 17.22% in 2023, then grew 2.16% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $3.6 billion in 2021, then increased by 13.27% to $4.1 billion in 2022, then rose by 10.5% to $4.5 billion in 2023, then rose by 2.16% to $4.6 billion in 2024, then increased by 9.49% to $5.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $5.1 billion in Q3 2025, $4.9 billion in Q2 2025, and $4.7 billion in Q1 2025.